Use of biosimilars in paediatric inflammatory bowel disease: A position statement of the ESPGHAN paediatric IBD porto group

2015

Additional Metadata
Keywords	Biosimilar, Inflammatory bowel disease, Infliximab, Paediatric, Position paper
Persistent URL	dx.doi.org/10.1097/MPG.0000000000000903, hdl.handle.net/1765/85070
Journal	Journal of Pediatric Gastroenterology and Nutrition
Organisation	Department of Pediatrics
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	de Ridder, L, Waterman, M, Turner, D, Bronsky, J, Hauer, A, Dias, J.A, … Lionetti, P. (2015). Use of biosimilars in paediatric inflammatory bowel disease: A position statement of the ESPGHAN paediatric IBD porto group. Journal of Pediatric Gastroenterology and Nutrition, 61(4), 503–508. doi:10.1097/MPG.0000000000000903

Publication